Post by
stockbuphoon on Feb 09, 2022 9:55am
Running LMNL into the ground
Amazing that they received 70% of voucher money and spending it all on extended analysis of a Phase 1 MAD study and GALBRAITH's preclinical molecule trials. They are not even trying to hide that they are going to run this company into the ground without another Phase 2 trial for 4050. The question becomes: were Lynn Gagnon and John Moran lying about the positive results of 4050 trials from years ago or are current management lying about there being no potential on any of 4050 indications after those positive trials? I would tend to think that Gagnon and Moran had more credibility than an accountant Pritchard.